Vote Scores

Home / Companies / Kiniksa Pharmaceuticals International, plc / 3 Jun 2025

Meeting · year to 30 June 2025301 filers reporting

Kiniksa Pharmaceuticals International, plc: meeting of 3 Jun 2025

Votes reported on Form N-PX, item by item

301 Form N-PX filers reported votes at the Kiniksa Pharmaceuticals International, plc meeting of 3 Jun 2025. Their records fall into 8 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

10 nominees; 75.5% of reported votes for; 89 filers withheld from or voted against at least one nominee.

1,810 vote records from 105 filers. 4 of the 105 filers that marked the item either way voted against management.

96.2% for2.9% against1.0% other3.8% against management105 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

553 vote records from 298 filers. 29 of the 292 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.

87.6% for9.7% against2.7% other9.9% against management298 filers98.9% for1.1% against0.0% other0.9% against management47,084,331 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

542 vote records from 105 filers. 1 of the 105 filers that marked the item either way voted against management.

99.0% for0.0% against1.0% other1.0% against management105 filers99.9% for0.0% against0.1% other0.1% against management30,666,935 reported shares
4

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

143 vote records from 81 filers. 0 of the 81 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management81 filers100.0% for0.0% against0.0% against management9,548,993 reported shares, counted once per item in this group
5

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

385 vote records from 105 filers. 58 of the 105 filers that marked the item either way voted against management.

40.0% for57.1% against2.9% other55.2% against management105 filers75.0% for24.9% against0.1% other23.9% against management20,954,950 reported shares, counted once per item in this group
6

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

313 vote records from 100 filers. 4 of the 100 filers that marked the item either way voted against management.

95.0% for3.0% against2.0% other4.0% against management100 filers99.5% for0.4% against0.2% other0.5% against management16,347,822 reported shares, counted once per item in this group
7

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

169 vote records from 96 filers. 1 of the 96 filers that marked the item either way voted against management.

99.0% for0.0% against1.0% other1.0% against management96 filers99.9% for0.0% against0.1% other0.1% against management10,060,768 reported shares, counted once per item in this group
8

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

28 vote records from 11 filers. 0 of the 11 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management11 filers100.0% for0.0% against0.0% against management435,527 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalAgainst *ForFor
State Street and SPDRForForFor
American CenturyForAgainst *For
Franklin TempletonForForFor
InvescoForAgainst *For
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganNo reportForNo report
Goldman SachsForForFor
WisdomTreeForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaAgainst *ForFor
First TrustForForFor
Russell InvestmentsNo reportForNo report
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonNo reportForNo report
PrincipalForForFor
Pacific Life fundsForForFor
Global XForForFor
MFSForForFor
AllianceBernsteinNo reportForNo report
DWSForForFor
PIMCONo reportForNo report
AllspringForForFor
Harbor FundsForForFor
Macquarie and Delaware FundsForForFor
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Kiniksa Pharmaceuticals International, plc meeting?

301 Form N-PX filers reported votes at the meeting of 3 Jun 2025. On say-on-pay, 29 of 292 voted against management (9.9%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Kiniksa Pharmaceuticals International, plc on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Kiniksa Pharmaceuticals International, plc

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Kiniksa Pharmaceuticals International, plc with a meeting date within three days of 3 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.